Generic competition · all medicines · read 12 November 2026
Is there a generic of Ciprofloxacin Hydrochloride, and who makes it?
Ciprofloxacin Hydrochloride appears in 5 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 14 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came between 13.4 and 16.6 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.
- Ciprofloxacin Hydrochloride appears in 5 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 14 generic makers listed as marketed across them.
- 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Where both are dated, the first generic approval came between 13.4 and 16.6 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Tablet, Oral
Four or more generic makers listed
Brand listed as marketed: Cipro. 10 generic makers with 27 generic products listed as marketed; the first generic approval is dated 9 June 2004.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Aiping Pharmaceutical Inc | 9 June 2004 | 3 |
| Carlsbad Technology Inc | 9 June 2004 | 3 |
| Dr Reddys Laboratories Ltd | 9 June 2004 | 3 |
| Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa | 9 June 2004 | 3 |
| Rising Pharma Holding Inc | 9 June 2004 | 1 |
| Watson Laboratories Inc | 9 June 2004 | 3 |
| Unique Pharmaceutical Laboratories A Div Of Jb Chemicals And Pharmaceuticals Ltd | 10 September 2004 | 3 |
| Chartwell Life Molecules Llc | 4 November 2004 | 3 |
| Aurobindo Pharma Ltd | 26 April 2007 | 3 |
| Pharmobedient Consulting Llc | 22 June 2018 | 2 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Solution/Drops, Ophthalmic
Four or more generic makers listed
Brand listed as marketed: Ciloxan. 5 generic makers with 5 generic products listed as marketed; the first generic approval is dated 9 June 2004.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Rubicon Research Ltd | 9 June 2004 | 1 |
| Watson Laboratories Inc | 21 January 2005 | 1 |
| Rising Pharma Holdings Inc | 13 December 2006 | 1 |
| Fdc Ltd | 30 June 2008 | 1 |
| Altaire Pharmaceuticals Inc | 3 May 2018 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Solution/Drops, Otic
One to three generic makers listed
Brand listed as marketed: Cetraxal. 1 generic maker with 1 generic product listed as marketed; the first generic approval is dated 5 November 2024.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Alembic Therapeutics Llc | 5 November 2024 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Ointment, Ophthalmic
Brand listed, no generic listed as marketed
Brand listed as marketed: Ciloxan. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Tablet, Extended Release, Oral
Nothing listed as marketed
Every brand product here is listed as discontinued. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.